Abstract
Although hyperoxic exposure is an important contributor to the development of bronchopulmonary dysplasia and nitric oxide (NO) has been implicated in the pulmonary response to oxygen, the role of NO in mediating chronic neonatal lung injury is unclear. Therefore, rat pups were exposed to normoxia or hyperoxia (>95% O2) from d 21 to 29. After the rats were killed, their lungs were removed for analysis of nitric oxide synthase (NOS) expression, NO activity as measured by 3′,5′-cyclic guanosine monophosphate (cGMP) assay, and lung pathology. Hyperoxia caused 5-fold and 2-fold increases in inducible (i) NOS and endothelial (e) NOS levels, respectively. NO activity was assessed by measuring cGMP levels after normoxic or hyperoxic exposure in the presence and absence of NOS blockade with either aminoguanidine (AG) or Nω-nitro-L-arginine (L-NNA). cGMP levels were elevated in hyperoxic versus normoxic rats (287 ± 15 versus 106 ± 9 pmol/mg protein, respectively, p < 0.001), and this increase in cGMP was attenuated after NOS blockade with either AG or L-NNA. Hyperoxic exposure significantly increased lung/body weight ratios and induced histologic changes of interstitial and alveolar edema; however, these hyperoxia-induced histologic changes were not altered by NOS blockade with AG or L-NNA. We conclude that hyperoxic exposure of rat pups up-regulated both iNOS and eNOS and increased NO activity as measured by cGMP levels derived from both iNOS and eNOS. Blockade of NOS reduced cGMP levels in the hyperoxic rat pups; however, it did not seem to reverse the pathologic consequences of hyperoxic exposure.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- NO:
-
nitric oxide
- NOS:
-
nitric oxide synthase
- iNOS:
-
inducible nitric oxide synthase
- eNOS:
-
endothelial nitric oxide synthase
- cGMP:
-
3′,5′-cyclic guanosine monophosphate
- AG:
-
aminoguanidine
- L-NNA:
-
Nω-nitro-L-arginine
References
Abman SH, Groothius JR 1994 Pathophysiology and treatment of bronchopulmonary dysplasia. Pediatr Clin N Am 41: 277–315.
Bancalari E 1997 Neonatal chronic lung disease. In: Fanaroff AA, Martin RJ (eds) Neonatal-Perinatal Medicine, 6th ed. Mosby, St. Louis, 1074–1089.
Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S 1994 Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94: 2407–2413.
Guidot DM, Repine MJ, Hybertson BM, Repine JE 1995 Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. Am J Physiol 269: L2–L5.
Pierce MR, Voelker CA, Sosenko IRS, Bustamante S, Olister SM, Zhang XJ, Clark DA, Miller MJS 1995 Nitric Oxide synthase inhibition decreases tolerance to hyperoxia in newborn rats. Mediators Inflammation 4: 431–436.
Robbins CG, Davis JM, Merritt TA, Amirkhanian JD, Sahgal N, Morin FC, Horowitz S 1995 Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol 269: L545–L550.
Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL 1996 Nitric oxide synthase generates superoxide and nitric oxide in arginine-dependent cells leading to peroxynitrite- mediated cellular injury. Proc Natl Acad Sci USA 93: 6770–6774.
McElroy MC, Wiener-Kronish JP, Miyazaki H, Sawa T, Modelska K, Dobbs LG, Pittet JF 1997 Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats. Am J Physiol 272: L631–L638.
Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002–2012.
Förstermann U, Kleinert H, Gath I, Schwarz P, Closs EI, Dun NJ 1995 Expression and expressional control of nitric oxide synthases in various cell types. Adv Pharmacol 34: 171–186.
Rairigh RL, Le Cras TD, Ivy DD, Kinsella JP, Richter G, Horan MP, Fan ID, Abman SH 1998 Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus. J Clin Invest 101: 15–21.
North AJ, Lau KS, Brannon TS, Wu LC, Wells LB, German Z, Shaul PW 1996 Oxygen upregulates nitric oxide synthase gene expression in ovine fetal pulmonary artery endothelial cells. Am J Physiol 270: L643–L649.
Cross AH, Misko TP, Lin RF, Hickey WF, Trototer JL, Tilton RG 1994 Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93: 2684–2690.
Bansinath M, Arbabha B, Turndorf H, Garg UC 1993 Chronic administration of a nitric oxide synthase inhibitor, N-nitro-L-arginine, and drug induced increase in cerebellar cyclic GMP in vivo. Neurochem Res 18: 1063–1066.
Whitacre CM, Berger NA 1997 Factors affecting topotecan-induced programmed cell death: adhesion protects cells from apoptosis and impairs cleavage of poly(ADP-ribose)polymerase. Cancer Res 57: 2157–2163.
Barnes PJ 1993 Nitric oxide and airways. Eur Respir J 6: 163–165.
Pryor WA, Squadrito GL 1995 The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268: L699–L722.
Halbower AC, Tuder RM, Franklin WA, Pollock JS, Forstermann U, Abman SH 1994 Maturation-related changes in endothelial nitric oxide synthase immunolocalization in developing ovine lung. Am J Physiol 267: L585–L591.
North AJ, Star RA, Brannon TS, Ujiie K, Wells LB, Lowenstein CJ, Snyder SH, Shaul PW 1994 Nitric oxide synthase type I and type III gene expression are developmentally regulated in rat lung. Am J Physiol 266: L635–L641.
Buttery LDK, Springall DR, da Costa FAM, Oliveira H, Hislop AA, Haworth SG, Polak JA 1995 Early abundance of nerves containing NO synthase in the airways of newborn pigs and subsequent decrease with age. Neurosci Lett 201: 219–222.
Xue C, Reynolds PR, Johns RA 1996 Developmental expression of NOS isoforms in fetal rat lung: implications for transitional circulation and pulmonary angiogenesis. Am J Physiol 270: L88–L100.
Kawai N, Block DB, Filippov G, Rabkina D, Suen HC, Losty PD, Janssens SP, Zapol WM, de la Monte S, Block KD 1995 Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am J Physiol 268: L589–L595.
Bloch KD, Filippov G, Sanchez LS, Nakane M, de la Monte SM 1997 Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increase during the perinatal period. Am J Physiol 272: L400–L406.
Arkovitz MS, Szabo C, Garcia FV, Wong HR, Wispe JR 1997 Differential effects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung. Shock 75: 345–350.
Ruetten H, Thiemermann C 1996 Prevention of the expression of inducible nitric oxide synthase by aminoguanidine or aminoethyl-isothiourea in macrophages and in the rat. Biochem Biophys Res Comm 225: 525–530.
Dorger M, Jesch NK, Rieder G, Hirvonen MR, Savolainen K, Krombach F, Messmer K 1997 Species differences in NO formation by rat and hamster alveolar macrophages in vitro. Am J Respir Cell Mol Biol 16: 413–420.
Nozik ES, Huang YC, Piantadosi CA 1995 L-Arginine enhances injury in the isolated rabbit lung during hyperoxia. Resp Physiol 100: 63–74.
Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch S, Cheng S, Cassin S 1996 Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol 270: L273–L280.
Narula P, Xu J, Kazzaz JA, Robbins CG, Davis JM, Horowitz S 1998 Synergistic cytotoxicity from nitric oxide and hyperoxia in cultured lung cells. Am J Physiol 274: L411–L416.
Capellier G, Maupoli V, Boillot A, Kantelip JP, Rochette L, Regnard J, Barale F 1996 L-NAME aggravates pulmonary oxygen toxicity in rats. Eur Respir J 9: 2531–2536.
Garat C, Jayr C, Eddahibi S, Laffon M, Meignan M, Adnot S 1997 Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med 155: 1957–1964.
Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH 1997 Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41: 457–463.
Nelin LD, Welty SE, Morrisey JF, Gotuaco C, Dawson CA 1998 Nitric oxide increases the survival of rats with a high oxygen exposure. Pediatr Res 43: 727–732.
Hershenson MB, Wylam ME, Punjabi N, Umans JG, Schumacher PT, Mitchell RW, Solway J 1994 Exposure of immature rats to hyperoxia increases tracheal smooth muscle stress generation in vitro. J Appl Physiol 76: 743–749.
Moore TM, Khimenko PL, Wilson PS, Taylor AE 1996 Role of nitric oxide in lung ischemia and reperfusion injury. Am J Physiol 271: H1970–H1977.
Fullerton DA, Eisenach JH, McIntyre RC, Friese RS, Sheridan BC, Roe GB, Agrafojo J, Banerjee A, Harken AH 1996 Inhaled nitric oxide prevents pulmonary endothelial dysfunction after mesenteric ischemia-reperfusion. Am J Physiol 271: L326–L331.
Barbotin-Larrieu F, Mazmanian M, Baudet B, Detruit H, Chapelier A, Libert JM, Dartevelle P, Herve P 1996 Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol 80: 782–788.
Author information
Authors and Affiliations
Additional information
Supported by NIH Grants HL-56470 (R.J.M.) and HL-50527 (M.A.H.).
Rights and permissions
About this article
Cite this article
Potter, C., Kuo, NT., Farver, C. et al. Effects of Hyperoxia on Nitric Oxide Synthase Expression, Nitric Oxide Activity, and Lung Injury in Rat Pups. Pediatr Res 45, 8–13 (1999). https://doi.org/10.1203/00006450-199901000-00003
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199901000-00003
This article is cited by
-
Neonatal exposure to hyperoxia leads to persistent disturbances in pulmonary histone signatures associated with NOS3 and STAT3 in a mouse model
Clinical Epigenetics (2018)
-
Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury
Respiratory Research (2009)
-
The role of nitric oxide in hyperoxic lung injury in premature rats
Journal of Tongji Medical University (2001)
